FDA 510(k) clears Medtronic’s Tyrx envelope for DBS devices

by Brad Perriello for MassDevice.com

Medtronic (NYSE:MDT) said today that it’s launching its Tyrx surgical envelope in the U.S. for use with deep-brain stimulation devices, after it won 510(k) clearance from the FDA for use of the infection-fighting envelope with implantable neurostimulators.

Fridley, Minn.-based Medtronic said it’s planning to make the Tyrx device, acquired for $160 million in January 2014, available for other neurostim indications “in the coming months.”

The device is designed to elute a pair of anti-microbial drugs, minocycline and rifampin, for 7 days. The envelope is designed to then dissolve over a period of roughly 9 weeks.

“The Tyrx Neuro absorbable antibacterial envelope is a much needed and long awaited solution to the risk of infection related to implantable neurostimulators. It is going to be the standard of care in my practice,”Dr. Francisco Ponce of the Barrow Neurological Institute in Phoenix, who performed the 1st DBS implantations with the Tyrx envelope, said in prepared remarks. “I am excited about this technology and the potential clinical and economic benefits it may offer our patients, our practice, and the healthcare system.”

See the full article here

With nearly 62,000 510(k) summaries to search, including more than 76,000 splash pages (more than 138,000 records total), quickly find your primary predicate, multiple predicates or reference devices with kBLASTER. Save time with kBLASTER's effective result management features of sorting, My Favorites, Saved Search and Search History from a web browser to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spending by enabling self-service extraction of actionable insight from FDA medical device 510(k) clearance summaries.